Recurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes
1 clinical trials · Condition
◉ Watch Recurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes
| Record | Firm | Date |
|---|---|---|
| Clinical Study of TQB2618 Injection in Combination With Demethylation Drugs in Patients With Recurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes (NCT05426798) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2022-04-29 |
Track Recurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes automatically
Every clearance here is in the API, with alerts when new ones post.